Literature DB >> 31492482

Procedural outcomes of deep brain stimulation (DBS) surgery in rural and urban patient population settings.

Michael Fana1, Gregory Everett2, Thomas Fagan2, Megan Mazzella2, Sulmaz Zahedi2, John M Clements3.   

Abstract

Presently, disparities exist between race, sex, socioeconomic status, hospitals, income, comorbidities, and insurance profiles of patients undergoing DBS surgery. Here, we aim to highlight several variables and their predictive powers of DBS surgery outcomes as measured by dischargelocation, length of hospital stays, and total hospital charges. A retrospective cohort study using discharge data from NIS and HCUP for analyses and regression model statistics is performed. Comparative analyses demonstrate urban patients were more often non-routinely discharged, possessed private insurance, and accrued greater hospital costs compared to rural patients. Moreover, regression analyses predicts urban patients have 70% lower odds of routine discharge while those with a major loss of function prior to surgery also have 81% lower odds of routine discharge compared to those with minor loss of function. Ultimately, our study found urban patients or patients with major illnesses have higher hospital charges, longer hospitalization, and more often non-routinely discharged.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Deep brain stimulation; Hospital costs; Hospital stay; Routine disposition; Rural patients; Urban patients

Mesh:

Year:  2019        PMID: 31492482     DOI: 10.1016/j.jocn.2019.08.117

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  1 in total

1.  Persistent Racial Disparities in Deep Brain Stimulation for Parkinson's Disease.

Authors:  Samuel W Cramer; Truong H Do; Elise F Palzer; Anant Naik; Abigail L Rice; Savannah G Novy; Jacob T Hanson; Amber N Piazza; Madeleine A Howard; Jared D Huling; Clark C Chen; Robert A McGovern
Journal:  Ann Neurol       Date:  2022-05-10       Impact factor: 11.274

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.